X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA FULFORD INDIA PLETHICO PHARMA/
FULFORD INDIA
 
P/E (TTM) x -1.1 398.8 - View Chart
P/BV x 0.0 6.2 0.3% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 PLETHICO PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
FULFORD INDIA
Mar-14
PLETHICO PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs395942 41.9%   
Low Rs31450 7.0%   
Sales per share (Unadj.) Rs604.4691.4 87.4%  
Earnings per share (Unadj.) Rs32.511.5 283.4%  
Cash flow per share (Unadj.) Rs51.315.4 334.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.3 0.0%  
Book value per share (Unadj.) Rs473.6380.0 124.6%  
Shares outstanding (eoy) m34.083.90 873.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.41.0 35.0%   
Avg P/E ratio x6.660.7 10.8%  
P/CF ratio (eoy) x4.245.3 9.2%  
Price / Book Value ratio x0.51.8 24.6%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m7,2622,714 267.6%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m1,596505 316.0%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m20,5982,696 763.9%  
Other income Rs m386125 308.1%   
Total revenues Rs m20,9842,822 743.7%   
Gross profit Rs m2,818-46 -6,072.5%  
Depreciation Rs m64215 4,225.7%   
Interest Rs m1,59310 16,770.5%   
Profit before tax Rs m96954 1,783.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-13810 -1,441.5%   
Profit after tax Rs m1,10745 2,476.2%  
Gross profit margin %13.7-1.7 -794.9%  
Effective tax rate %-14.317.7 -80.8%   
Net profit margin %5.41.7 324.2%  
BALANCE SHEET DATA
Current assets Rs m18,8771,738 1,085.9%   
Current liabilities Rs m11,896545 2,184.0%   
Net working cap to sales %33.944.3 76.6%  
Current ratio x1.63.2 49.7%  
Inventory Days Days3648 74.1%  
Debtors Days Days1984 4,595.6%  
Net fixed assets Rs m9,86112 82,861.3%   
Share capital Rs m34139 873.6%   
"Free" reserves Rs m12,3311,443 854.5%   
Net worth Rs m16,1391,482 1,089.0%   
Long term debt Rs m4,7060-   
Total assets Rs m33,1462,077 1,596.1%  
Interest coverage x1.66.7 23.9%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.61.3 47.9%   
Return on assets %8.12.6 312.1%  
Return on equity %6.93.0 227.4%  
Return on capital %12.34.3 285.5%  
Exports to sales %21.40-   
Imports to sales %15.224.5 62.3%   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136659 475.7%   
Fx inflow Rs m4,40217 25,595.3%   
Fx outflow Rs m3,184673 473.0%   
Net fx Rs m1,219-656 -185.8%   
CASH FLOW
From Operations Rs m2,43790 2,708.2%  
From Investments Rs m-6,265105 -5,989.2%  
From Financial Activity Rs m2,490-14 -17,660.3%  
Net Cashflow Rs m-1,337181 -740.8%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.3 3.8 113.2%  
FIIs % 5.5 0.1 5,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 21.2 35.4%  
Shareholders   10,665 4,783 223.0%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  ASTRAZENECA PHARMA  BIOCON LTD  

Compare PLETHICO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS